{"transactions":[{"id":749922,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":41429,"kind":"person","name":"Doyle Janeen Noel","position":1,"cik":"0002069239","reported_name":"Doyle Janeen Noel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. & Bus. Dev. Ofcr"}}],"security":"Common Stock","published_at":"2026-06-05T00:00:06.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":4059,"price":14.029,"value":56943.711,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $14.029 and the range of prices were between $13.96 and $14.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":75941,"source":{"system":"sec-edgar","filing":"0002069239-26-000005","document":"form4-06042026_080601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069239/000206923926000005/form4-06042026_080601.xml","form_type":"4"}},{"id":955435,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":41429,"kind":"person","name":"Doyle Janeen Noel","position":1,"cik":"0002069239","reported_name":"Doyle Janeen Noel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. & Bus. Dev. Ofcr"}}],"security":"Stock option (right to buy)","published_at":"2026-01-03T02:00:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":126000,"derivative":{"exercise_price":13.65,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0002069239-26-000002","document":"form4-01022026_090103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2069239/000206923926000002/form4-01022026_090103.xml","form_type":"4"}},{"id":955434,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":41429,"kind":"person","name":"Doyle Janeen Noel","position":1,"cik":"0002069239","reported_name":"Doyle Janeen Noel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. & Bus. Dev. Ofcr"}}],"security":"Common Stock","published_at":"2026-01-03T02:00:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0002069239-26-000002","document":"form4-01022026_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069239/000206923926000002/form4-01022026_090103.xml","form_type":"4"}},{"id":1123280,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":41429,"kind":"person","name":"Doyle Janeen Noel","position":1,"cik":"0002069239","reported_name":"Doyle Janeen Noel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. & Bus. Dev. Ofcr"}}],"security":"Stock option (right to buy)","published_at":"2025-06-05T00:00:20.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":154000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on May 14, 2026 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":154000,"derivative":{"exercise_price":25.01,"expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":154000},"source":{"system":"sec-edgar","filing":"0001415889-25-015684","document":"form4-06042025_080616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2069239/000141588925015684/form4-06042025_080616.xml","form_type":"4"}},{"id":1123279,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":41429,"kind":"person","name":"Doyle Janeen Noel","position":1,"cik":"0002069239","reported_name":"Doyle Janeen Noel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Corp. & Bus. Dev. Ofcr"}}],"security":"Common Stock","published_at":"2025-06-05T00:00:20.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on June 1, 2026."}],"balance_after":44000,"source":{"system":"sec-edgar","filing":"0001415889-25-015684","document":"form4-06042025_080616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2069239/000141588925015684/form4-06042025_080616.xml","form_type":"4"}}]}